Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health

Summary

The goal of this prospective, multicenter, open-label randomized controlled clinical trial is to evaluate whether a home-based, digitally supervised multi-modal prehabilitation intervention can improve functional capacity, treatment tolerance, and short- and long-term clinical outcomes in gastric cancer patients who have completed 2-4 cycles of neoadjuvant chemotherapy and are scheduled for radical gastrectomy.

Conditions

• Gastric Cancer
• Prehabilitation

Interventions

BEHAVIORAL

mHealth prehabilitation group

receiving at least 4 weeks of 5G+AI digitally supervised home-based multi-modal prehabilitation plus standard ERAS perioperative management

OTHER

ERAS group

The management of ERAS group was carried out in accordance with the standard ERAS protocol from admission until 30 days postdischarge. The ERAS program mainly included malnutrition screening, health education, surgical risk assessment, and smoking and drinking cessation.

Sponsors & Collaborators

• People's Hospital of Xinjiang Uygur Autonomous Region

  collaborator OTHER

• First Affiliated Hospital, Sun Yat-Sen University

  collaborator OTHER

• Sixth Affiliated Hospital, Sun Yat-sen University

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• The Second Hospital of Shandong University

  collaborator OTHER

• Yantai Yuhuangding Hospital

  collaborator OTHER

• The Affiliated Hospital of Shandong Second Medical University

  collaborator UNKNOWN

• Weifang People's Hospital

  collaborator OTHER

• Shandong Cancer Hospital and Institute

  collaborator OTHER

• Dongying People's Hospital

  collaborator OTHER

• Rizhao People's Hospital

  collaborator OTHER

• Jining First People's Hospital

  collaborator OTHER

• Peking University Cancer Hospital (Inner Mongolia Campus)

  collaborator UNKNOWN

• The Affiliated Hospital of Qingdao University

  lead OTHER

Principal Investigators

• Yanbing Zhou · The Affiliated Hospital of Qingdao University

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2026-08-31

Primary Completion

2028-09-01

Completion

2030-09-01